Taurine: A therapeutic agent in experimental kidney disease

Amino Acids

Volumn 11, Issue 1, 1996, Pages 1-13

  Trachtman, H ^a   Sturman, J A ^b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Antioxidant; Diabetic nephropathy; Focal segmental glomerulosclerosis; Hypertension; Lipid peroxidation; Puromycin aminonucleoside nephropathy; Taurine

Indexed keywords

AMINO ACID; AMIODARONE; ANTIOXIDANT; BLEOMYCIN; GLUCOSE; NICOTINIC ACID; TAURINE;

ACUTE KIDNEY FAILURE; ARTICLE; CELL HYPOXIA; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DRUG MECHANISM; GLOMERULOPATHY; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY MASS; KIDNEY TUBULE EPITHELIUM; LIPID PEROXIDATION; LUNG FIBROSIS; MESANGIUM; NEPHRON; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0029760170     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00805717     Document Type: Article

References (77)

1. Amiry-Moghaddam M, Nagelhus E, Ottersen OP (1994) Light- and electron microscopic distribution of taurine, an organic osmolyte, in rat renal tubule cells. Kidney Int 45: 10-22
2. Arouma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine, and their metabolic precursors. Biochem J 256: 251-255
3. Baines AD, Shaikh N, Ho P (1990) Mechanisms of perfused kidney cytoprotection by alanine and glycine. Am J Physiol 259: F80-F87
4. Banks MA, Porter DW, Martin WG, Castranova V (1990) Effects of in vitro ozone exposure on peroxidative damage: membrane leakage and taurine content of rat alveolar macrophages. Toxicol Appl Pharmacol 105: 55-65
5. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412
6. Bergstrom J, Alvestrand A, Furst P, Lindholm B (1989) Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion. J Intern Med 226: 189-194
7. Brenner BM, Anderson S (1992) The interrelationships among filtration surface area, blood pressure, and chronic renal disease. J Cardiovasc Pharmacol 19 [Suppl] 6: S1-S7
8. Cantin AM (1994) Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro: role of anion transport. J Clin Invest 93: 606-614
9. Ceballos I, Chauveau P, Guerin V, Bardet J, Parvy P, Kamoun P, Jungers P (1990) Early alterations of plasma free amino acids in chronic renal failure. Clin Chim Acta 188: 101-108
10. Chesney RW (1985) Taurine: its biological role and clinical implications. Adv Pediatr 32: 1-42
11. Chesney RW, Gusowski N, Dabbagh S (1985) Renal cortex taurine content regulates renal adaptive response to altered dietary intake of sulfur amino acids. J Clin Invest 76:2213-2221
12. Chesney RW, Gusowski N, Zelikovic I, Padilla M (1986) Developmental aspects of renal β-amino acid transport. V. Brush border membrane transport in nursing animals: effect of age and diet. Pediatr Res 20: 890-894
13. Culpepper RW, Schoolwerth AC (1992) Remnant kidney oxygen consumption: hypermetabolism or hyperbole? J Am Soc Nephrol 3: 151-156
14. Diamond JR, Bonventre JV, Karnovsky MJ (1986) A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29: 478-483
15. Endreffy E, Turi S, Laszik Z, Bereczki C, Kasa K (1991) Effects of vitamin E on tissue oxidation in nephrotoxic (anti-glomerular basement membrane) nephritis. Pediatr Nephrol 5: 312-317
16. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, Seghieri G (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61: 1115-1119
17. Fujita T, Sato Y (1988) Hypotensive effect of taurine: possible involvement of the sympathetic nervous system and endogenous opiates. J Clin Invest 82: 993-997
18. Fujita T, Sato Y, Ando K (1986) Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats. Am J Physiol 251: H926-H933
19. Fujita T, Ando K, Noda H, Ito Y, Sato Y (1987) Effects of increased adrenomedullary activity and tauring in young patients with borderline hypertension. Circulation 75: 525-532
20. Gaull GE (1989) Taurine in pediatric nutrition: review and update. Pediatrics 83: 433-442
21. Ginveri F, Gusmano R, Oleggini R, et al. (1990) Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis. Clin Sci 78: 283-293
22. Goodman HO, Shihabi ZK (1990) Supplemental taurihne in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43: 1-9
23. 2-induced alterations. Am J Pathol 125: 585-600
24. Grond J, Weening JJ, Elema JD (1984) Glomerular sclerosis in nephrotic rats: comparison of the long-term effects of adriamycin and aminonucleoside. Lab Invest 51: 277-284
25. Hamaguchi T, Azuma J, Harada H, Takahashi K, Kishimoto S, Schaffer SW (1989) Protective effect of taurine against doxorubicin-induced cardiotoxicity in perfused chick hearts. Pharmacol Res 21: 729-734
26. Heyman S, Spokes K, Rosen S, Epstein FH (1992) Mechanism of glycine protection in hypoxic injury: analogies with glycine receptor. Kidney Int 42: 41-45
27. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72: 101-163
28. Ideishi M, Miura S, Sakai T, Sasaguri M, Misumi Y, Arakawa K (1994) Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 12: 653-661
29. Jacobsen JG, Smith LH Jr (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48: 424-511
30. Johnson RJ (1994) The glomerular response to injury: progression or resolution? Kidney Int 45: 1769-1782
31. Jones DP, Miller LA, Chesney RW (1990) Adaptive regulation of taurine transport in two continuous renal epithelial cell lines. Kidney Int 38: 219-226
32. 1 and MDCK cells: further characterization of divergent transport models. Amino Acids 5: 329-339
33. 1 and MDCK cells. Pediatr Res 37: 227-232
34. Jung BC, Laidlaw SA, Kopple JD (1991) Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis. Am J Kidney Dis 18: 74-79
35. Klahr S, Schreiner G, Ichikawa I (1988) The progression of renal disease. N Engl J Med 318: 1657-1666
36. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL (1994) Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43: 1372-1377
37. Li JZ, Sharma R, Dileepan KN, Savin VJ (1994) Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int 46: 1025-1030
38. Ma N, Aoki E, Semba R (1994) An immunohistochemical study of aspartate, glutamate and taurine in rat kidney, J Histochem Cytochem 42: 621-626
39. Michalk DV, Essich HJ, Bohles HJ, Scharer K (1983) Taurine metabolism in experimental renal failure. Kidney Int 24 [Suppl]: S16-S21
40. Nakamori K, Koyama I, Nakamura T, Nemoto M, Yoshida T, Umeda M, Inoue K (1993) Quantitative evaluation of the effectiveness of taurine in protecting the ocular surface against oxidant. Chem Pharm Bull 41: 335-338
41. Nakanishi T, Uyama O, Sugita M (1991) Osmotically regulated taurine content in rat renal inner medulla. Am J Physiol 261: F957-F962
42. Nankivell BJ, Tay YC, Boadle RA, Harris DCH (1994) Dietary protein alters tubular iron accumulation after partial nephrectomy. Kidney Int 45: 1006-1013
43. Nara Y, Yamori Y, Lovenberg W (1978) Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27: 2689-2692
44. Paller MS, Hoidal JR, Ferris TF (1984) Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74: 1156-1164
45. Pasantes-Morales H, Wright CE, Gaull GE (1984) Protective effect of taurine, zinc, and tocopherol on retinol-induced damage in human lymphoblastoid cells. J Nutr 114: 2256-2261
46. Pasantes-Morales H, Wright CE, Gaull GE (1985) Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 34: 2205-2207
47. Perfumo F, Canepa A, Divino-Filho JC, Nilsson E, Carrea A, Verrina E, Gusmano R, Bergstrom J (1994) Muscle and plasma amino acids and nutritional status in kidney-transplanted children. Nephrol Dial Transplant 9: 1778-1785
48. Schuller-Levis G, Quinn MR, Wright C, Park E (1994) Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. In: Huxtable R (ed) Taurine in health and disease. Plenum Press, New York, pp 31-39
49. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AAF, Greene DA (1993) Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36: 608-614
50. Storm-Mathisen J, Leknes AK, Bore AT, Vaaland JL, Edminson P, Haug FS, Ottersen OP (1983) First visualization of glutamate and GABA in neurones by immunocytochemistry. Nature: 517-520
51. Sturman JA (1993) Taurine in development. Physiol Rev 73: 119-147
52. Tadolini B, Pintus G, Pinna GG, Bennardini F, Franconi F (1995) Effects of taurine and hypotaurine on lipid peroxidation. Biochem Biophys Res Commun 213: 820-826
53. Thakur V, Walker PD, Shah SV (1988) Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34: 494-499
54. Thomas EL, Grisham MB, Melton DF, Jefferson MM (1985) Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. J Biol Chem 260: 3321-3329
55. Trachtman H (1994) Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc Res 47: 232-239
56. Trachtman H, Del Pizzo R (1989) Taurine does not afford protection against progressive renal failure in the 5/6 nephrectomy model of chronic renal disease. Am J Kidney Dis 14: 438 (abstract)
57. Trachtman H, Barbour R, Sturman JA, Finberg L (1988) Taurine is a cerebral osmoprotective molecule, "no longer idiogenic", in chronic hypernatremic dehydration. Pediatr Res 23: 35-39
58. Trachtman H, Del Pizzo R, Rao PS, Rujikarn N, Sturman JA (1989) Taurine lowers blood pressure in the spontaneously hypertensive rat by a catecholamine independent mechanism. Am J Hypertens 2: 909-912
59. Trachtman H, Del Pizzo R, Sturman JA (1990) Taurine and osmoregulation III. Taurine deficiency protects against cerebral edema during acute hyponatremia. Pediatr Res 27: 85-88
60. Trachtman H, Wilson D, Rao PS (1992a) The role of oxygen free radicals in the development of chronic renal failure. Life Sci 50: 1877-1883
61. Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E, Sturman JA (1992b) Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol 262: F117-F123
62. Trachtman H, Futterweit S, Bienkowski RS (1993a) Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem Biophys Res Commun 191: 759-765
63. Trachtman H, Lu P, Sturman JA (1993b) Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states. J Histochem Cytochem 41: 1209-1216
64. Trachtman H, Futterweit S, Prenner J, Hanon S (1994) Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Commun 199: 346-352
65. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH, Fu MX, Baynes J (1995) Taurine ameliorates chronic steptozocin-induced diabetic nephropathy in rats. Am J Physiol 269: F429-F438
66. Ucida S, Nakanishi T, Kwon HM, Preston AS, Handler JS (1991) Taurine behaves as an osmolyte in Madin-Darby canine cells: protection by polarized, regulated transport of taurine. J Clin Invest 88: 656-662
67. Venkatesan N, Rao PV, Arumugam V (1993) Inhibitory effect of taurine on puromycin aminonucleoside-induced hyperlipidemia in rats. J Clin Biochem Nutr 15: 203-210
68. Venkatesan N, Rao PV, Arumugam V (1994) In vivo protective effect of taurine on puromycin aminonucleoside-induced nephrosis in rats. J Clin Biochem Nutr 16: 91-100
69. Venkatesan N, Karthikeyan J, Arumugam V: Protection by taurine against adriamycin-induced hyperlipidemia and proteinuria in rats. Proc Soc Exp Biol Med (under review)
70. Walker PD, SV Shah (1988) Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure. J Clin Invest 81: 334-341
71. Wang Q, Hollinger MA, Giri SN (1992a) Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Therap 262: 127-132
72. Wang Q, Hyde DM, Giri SN (1992b) Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin. Lab Invest 67: 234-241
73. Weinberg JM, Venkatachalam MA, Roeser NF, Davis JA, Varani J, Johnson KJ (1991a) Amino acid protection of cultured kidney tubule cells against calcium ionophore-induced lethal cell injury. Lab Invest 65: 671-678
74. Weinberg JM, Nissim I, Roeser NF, Davis JA, Schultz S, Nissim I (1991b) Relationships between intracellular amino acid levels and protection against injury to isolated proximal tubules. Am J Physiol 260: F410-F419
75. Wingenfeld P, Strubind S, Gehrmann U, Minor T, Isselhard W, Michalk D (1994) Protecting effect of taurine against hypoxic cell damage in renal tubular cells cultured in different transplant presservation solutions. Adv Exp Med Biol 359: 159-169
76. Zelikovic I, Stejskal-Lorenz E, Lohstroh P, Budreau A, Chesney RW (1989) Anion dependence of taurine transport by rat renal brushborder membrane vesicles. Am J Physiol 256: F646-F655
77. Zelikovic I, Chesney RW, Friedman AL, Ahlfors CE (1990) Taurine depletion in very low birth weight infants receiving prolonged total parenteral nutrition: role of renal immaturity. J Pediatr 116: 301-306